Here's Why You Should Hold on to CONMED (CNMD) Stock for Now Zacks Equity Research - Zacks Investment Research - Tue Oct 15, 7:48AM CDT Zacks Equity Research - ZACKS - Tue Oct 15, 7:48AM CDT
CONMED (CNMD) raises 2019 revenue and earnings per share guidance.
CONMED Corporation to Announce Third Quarter 2019 Financial Results on October 30, 2019 BusinessWire - Mon Oct 7, 3:01PM CDT CMTX - Mon Oct 7, 3:01PM CDT
CONMED Corporation (NASDAQ:CNMD) today announced that it will report financial results for the third quarter of 2019 after the market close on Wednesday, October 30, 2019. The Company's management will...
Wright Medical G is Among the Companies in the Health Care Equipment Industry with the Best Relative Performance (WMGI , EW , CNMD , DHR , BSX ) Comtex SmarTrend(R) - Mon Oct 7, 3:28AM CDT CMTX - Mon Oct 7, 3:28AM CDT
Below are the top five companies in the Health Care Equipment industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that...
Laparotomy Sponges Market CAGR, Outlook By Key Players: Derma Sciences, Medtronic, Owens & Minor, Medline, A Plus International Reporthive Research - Thu Oct 3, 5:55PM CDT CMTX - Thu Oct 3, 5:55PM CDT
research report answers several questions (like current market status, future market opportunities, global and regional distribution) for stakeholders, primarily which market segments they should focus...
XRAY vs. CNMD: Which Stock Is the Better Value Option? Zacks Equity Research - Zacks Investment Research - Thu Oct 3, 8:30AM CDT Zacks Equity Research - ZACKS - Thu Oct 3, 8:30AM CDT
XRAY vs. CNMD: Which Stock Is the Better Value Option?
Here's Why You Should Retain HMS Holdings (HMSY) Stock For Now Zacks Equity Research - Zacks Investment Research - Mon Sep 30, 8:02AM CDT Zacks Equity Research - ZACKS - Mon Sep 30, 8:02AM CDT
HMS Holdings (HMSY) is gaining traction from growing PI and TPM analytical services as well as robust margins despite intense competition.
Cerner (CERN) Set to Improve Patient Experience With New Deal Zacks Equity Research - Zacks Investment Research - Wed Sep 25, 10:26AM CDT Zacks Equity Research - ZACKS - Wed Sep 25, 10:26AM CDT
The collaboration with GetWellNetwork is likely to allow Cerner (CERN) in enhancing functionality for clients and patients through third-party solutions.
Here's Why You Should Hold Onto Cerner (CERN) Stock for Now Zacks Equity Research - Zacks Investment Research - Wed Sep 25, 8:37AM CDT Zacks Equity Research - ZACKS - Wed Sep 25, 8:37AM CDT
Cerner (CERN) keeps its 2019 revenue guidance intact; expects improvement in bookings.
Here's Why You Should Hold on to Wright Medical (WMGI) Stock Zacks Equity Research - Zacks Investment Research - Tue Sep 24, 10:12AM CDT Zacks Equity Research - ZACKS - Tue Sep 24, 10:12AM CDT
Strong international footprint, solid prospects in the global orthopedic space and an enhanced product pipeline bode well for Wright Medical (WMGI). However, adverse forex mars prospects.
Shares of CNMD Up 58.9% Since Uptrend Call on Shares Comtex SmarTrend(R) - Mon Sep 23, 1:15PM CDT CMTX - Mon Sep 23, 1:15PM CDT
SmarTrend identified an Uptrend for Conmed Corp (NASDAQ:CNMD) on December 31st, 2018 at $63.09. In approximately 9 months, Conmed Corp has returned 58.92% as of today's recent price of $100.26.
Here's Why You Should Hold on to Nevro (NVRO) Stock for Now Zacks Equity Research - Zacks Investment Research - Mon Sep 23, 10:09AM CDT Zacks Equity Research - ZACKS - Mon Sep 23, 10:09AM CDT
Nevro (NVRO) is gaining traction from a fortified international footprint and solid prospects in the SCS market. However, stiff competition remains a woe.
CONMED Corporation Adds LaVerne Council and Barbara Schwarzentraub to its Board of Directors BusinessWire - Mon Sep 23, 7:00AM CDT CMTX - Mon Sep 23, 7:00AM CDT
CONMED Corporation (NASDAQ: CNMD) announced today that LaVerne Council and Barbara Schwarzentraub are joining its Board of Directors. Ms. Schwarzentraub will join the Board effective immediately, with...
Fresenius Medical Launches 4008A Dialysis Machine in China Zacks Equity Research - Zacks Investment Research - Fri Sep 20, 9:57AM CDT Zacks Equity Research - ZACKS - Fri Sep 20, 9:57AM CDT
Fresenius Medical (FMS) aims to treat ESRD patients in remote locations of China.
PRA Health Simplifies Treatment Decisions With Metys Launch Zacks Equity Research - Zacks Investment Research - Thu Sep 19, 9:25AM CDT Zacks Equity Research - ZACKS - Thu Sep 19, 9:25AM CDT
PRA Health (PRAH) expects to enhance position and capabilities in the data and analytics field with the new tool, while simplifying treatment decisions.
Here's Why You Should Retain Pacific Biosciences For Now Zacks Equity Research - Zacks Investment Research - Wed Sep 18, 8:59AM CDT Zacks Equity Research - ZACKS - Wed Sep 18, 8:59AM CDT
Pacific Biosciences (PACB) continues to gain from innovative product portfolio and Sequel system. However, contraction in gross margin remains a woe.
Accuray's (ARAY) CyberKnife Delivers Improved Patient Outcome Zacks Equity Research - Zacks Investment Research - Wed Sep 18, 8:25AM CDT Zacks Equity Research - ZACKS - Wed Sep 18, 8:25AM CDT
Accuray's (ARAY) CyberKnife delivers stereotactic body radiation therapy in only five sessions.
HMS Holdings Acquires VitreosHealth, Boosts PHM Solution Set Zacks Equity Research - Zacks Investment Research - Tue Sep 17, 9:18AM CDT Zacks Equity Research - ZACKS - Tue Sep 17, 9:18AM CDT
HMS Holdings (HMSY) can leverage VitreosHealth's prescriptive health insights that will enhance its growing and lucrative PHM suite.
Here's Why You Should Retain OPKO Health (OPK) Stock For Now Zacks Equity Research - Zacks Investment Research - Tue Sep 17, 9:00AM CDT Zacks Equity Research - ZACKS - Tue Sep 17, 9:00AM CDT
OPKO Health (OPK) continues to gain from RAYALDEE and BioReference platforms, and solid R&D focus. However, operating losses remain a woe.
Here's Why You Should Retain Patterson Companies (PDCO) Now Zacks Equity Research - Zacks Investment Research - Mon Sep 16, 8:47AM CDT Zacks Equity Research - ZACKS - Mon Sep 16, 8:47AM CDT
Patterson Companies (PDCO) continues to benefit from robust product portfolio, strong prospects in Animal Health unit and strategic buyouts. However, intense competition remains a woe.
60.7% Return Seen to Date on SmarTrend Conmed Corp Call (CNMD) Comtex SmarTrend(R) - Fri Sep 13, 11:04PM CDT CMTX - Fri Sep 13, 11:04PM CDT
SmarTrend identified an Uptrend for Conmed Corp (NASDAQ:CNMD) on December 31st, 2018 at $63.09. In approximately 9 months, Conmed Corp has returned 60.74% as of today's recent price of $101.41.
